Showing results (11-20 of 37) with videos related to

Sort By:
Pageof 4
BMC Cancer|April 1, 2025
Radiotherapy is enhanced by CPH:SA IL-1α microparticles in a murine HNSCC tumor modelM M Hasibuzzaman, Rui He, Ishrat Nourin Khan, et al.
Molecular Oncology|April 19, 2015
Upregulated interleukin-6 expression contributes to erlotinib resistance in head and neck squamous cell carcinomaAditya Stanam, Laurie Love-Homan, Tisha S Joseph, et al.
BMC Cancer|June 26, 2024
Prognostic Role of Tumor-Infiltrating Lymphocytes in Oral Squamous Cell CarcinomaWattawan Wongpattaraworakul, Allen Choi, Marisa R Buchakjian, et al.
ACS Biomaterials Science & Engineering|January 19, 2021
Combining Doxorubicin-Loaded PEGylated Poly(Lactide-co-glycolide) Nanoparticles with Checkpoint Inhibition Safely Enhances Therapeutic Efficacy in a Melanoma ModelKhanidtha Chitphet, Sean M Geary, Carlos H F Chan, et al.
Journal of Oncology|September 12, 2009
Inhibition of glutathione and thioredoxin metabolism enhances sensitivity to perifosine in head and neck cancer cellsAndrean L Simons, Arlene D Parsons, Katherine A Foster, et al.
Laboratory Investigation; a Journal of Technical Methods and Pathology|April 24, 2013
The Justy mutant mouse strain produces a spontaneous murine model of salivary gland cancer with myoepithelial and basal cell differentiationAndrean L Simons, Ping Lu, Katherine N Gibson-Corley, et al.
Oncology Research|May 15, 2016
2-Deoxy-d-glucose Suppresses the In Vivo Antitumor Efficacy of Erlotinib in Head and Neck Squamous Cell Carcinoma CellsArya Sobhakumari, Kevin P Orcutt, Laurie Love-Homan, et al.
Frontiers in Oncology|August 12, 2022
Prognostic Role of Combined EGFR and Tumor-Infiltrating Lymphocytes in Oral Squamous Cell CarcinomaWattawan Wongpattaraworakul, Katherine N Gibson-Corley, Allen Choi, et al.
Pageof 4